Pharmaceutical Enrofloxacin Hydrochloride Powder Enrofloxacin Hydrochloride hcl powder Raw Material Enrofloxacin Hcl
Product Description
Product Datails
| Product Name |
Enrofloxacin Hydrochloride |
| Purity |
99% |
| MF |
C19H22FN3O3 |
| Appearance |
White Powder |
| Test Method |
HPLC |
Enrofloxacin HCL is a broad spectrum bactericidal drugs,have special effects on mycoplasma.White on escherichia coli, klebsiella bacillus coli,pseudomonas aeruginosa,salmonella,deformation,haemophilus, kill,pasteurella,streptococcus hemolytic pap coli,s.aureus bacteria, such as have antiseptic effect.
Application&Function
Enrofloxacin hydrochloride is used for mycoplasma disease of chicken (chronic respiratory tract disease), colibacillosis of poultry, pullorum of chicken, salmonellosis of poultry, pasteurellosis of poultry, pullorum of piglets, yellow pullorum, edema type colibacillosis of pig, mycoplasma swollen bronchopneumonia of pig, pleural pneumonia, paratyphoid of piglets,As well as cattle, sheep, rabbits, dogs and other mycoplasma and bacterial diseases, can also be used for all kinds of bacterial infections of aquatic animals.
1.Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
2. Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
3. Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Specification
Audited Supplier 
){kind=link}
){kind=link}